Background
Regulatory T cells are a therapeutic strategy for immune dysregulated diseases and a potential target for cancer immunotherapy. In addition to CD4 + Foxp3 + regulatory T (Treg) cells, studies have emphasized the roles of CD4 + Foxp3
-regulatory T cells, such as TGF-β-producing T helper 3 (Th3) cells, IL-10-producing type 1 regulatory T (Tr1) cells, and others. Accumulating evidence demonstrate that naïve B cells possess the ability to promote naïve CD4 + T cells into CD25 + Foxp3 -regulatory T cells with the expression of lymphocyte activation gene-3 (LAG3, CD223), inducible co-stimulator (ICOS, CD278), programmed cell death protein 1 (PD1, CD279), and glucocorticoid-induced TNFR family-related protein (GITR). B-cell-induced CD4 +
Foxp3
-regulatory T cells exert the inhibition through both IL-10-independent and cell-cell contact-dependent mechanisms, although they also show IL-10-mediated suppression. Furthermore, these B cell-induced regulatory T cells protect mice from several immune disorders, including graft-versus-host disease, experimental allergic asthma, collagen-induced arthritis, and inflammatory bowel disease. Here, we review the phenotypes and functional mechanisms of thymus-derived and peripherally derived CD4 + T cells contributed to maintaining self-tolerance in a nonantigen-specific manner [1] . Immune dysregulation, polyendocrinophathy, enteropathy X-linked (IPEX) syndrome is a recessive immune disorder. Reports showed that IPEX is caused by mutations of FOXP3 gene, which is orthologouse of the Foxp3 gene mutated in scurfy mouse [2] [3] [4] . Further studies demonstrated that Foxp3 expressed predominantly in CD4 + CD25 + T cells than CD4 + CD25 -T and CD19 + B cells. Moreover, retroviral transduction of Foxp3 in naïve CD4 + CD25 -T cells converted these cells toward Treg cells phenotype. Thus, Foxp3 has been identified as the master transcription factor of Treg cells [5] .
Thymus-derived Foxp3
+ regulatory T cells
In addition to Foxp3, thymus-derived CD4 + CD25 + Foxp3 + regulatory T (tTreg) cells highly expressed Helios, cytotoxic T lymphocyte-associated antigen-4 (CTLA4, CD152), neuropilin-1, GITR, galectin-1, IL-10, and granzyme B [6] . tTreg cells could be activated in an antigenspecific fashion and exerted suppressive activity in a non-antigen-specific fashion [7] . tTreg cells produced many inhibitory cytokines, including TGF-β1, IL-10, and IL-35, to downregulate immune responses [8] . Furthermore, tTreg cells exhibited cell-cell contact-dependent suppression via latency-associated peptide (LAP) [9] , CD39 (ectonucleoside triphosphate diphosphohydrolase-1, ENTPD1) and CD73 (ecto-5′-nucleotidase) [10] , and cytosolic cyclic adenosine monophosphate (cAMP) [11] . Reports showed that tTreg cells induced effector T cell apoptosis via various pathways, including deprivation of IL-2 and IL-7 [12] , disruption of effector cell membrane integrity by granzyme B [13] , galectin-1-induced apoptosis [14] , and the engagement of TNF-related apoptosis inducing ligand (TRAIL)-death receptor 5 (DR5) [15] . Additionally, tTreg cells inhibited effector T cell activation via downregulation of costimulatory molecules on DCs through CTLA4 [16] and LAG3 [17] . These studies indicate that tTreg cells are a polyclonal population, and the above mentioned complicated mechanisms result in maximal immunosuppression during homeostasis.
Peripherally derived Foxp3
Foxp3
+ regulatory T cells induced in vivo are called peripherally derived regulatory T (pTreg) cells and those generated in vitro are called in vitro-induced regulatory T (iTreg) cells [18] . Studies demonstrated that CD4 + Foxp3   -T cells differentiated into Foxp3  + CD25  + CD45RB low anergic T cells with suppressive functions in the presence of TGF-β1 in vitro as well as in vivo [19] and rescue Foxp3-deficient scurfy mice [20] . In the absence of tTreg cells, oral antigen administration induced the generation of CD4 + CD25 + Foxp3 + regulatory T cells in a TGF-β1-dependent manner [21] . Gut-associated lymphoid tissue CD103 + DCs played an important role in the de novo conversion of naïve T cells into pTreg cells, and retinoic acid facilitates that process [22] . Additionally, lung-resident tissue macrophages expressed retinal dehydrogenases, and TGF-β1 promoted pTreg cell induction under steady-state conditions [23] . Evidence has shown that the tumor environment induced pTreg cell generation to escape immune clearance [24] . One report demonstrated that tTreg and pTreg cells shared similar phenotypes, and neuropilin-1 serving as a surface marker to distinguish tTreg cells from pTreg cells [25] .
CD4 +

Foxp3
-regulatory T cells
The most well-defined Foxp3 -regulatory T cells are Th3 cells and Tr1 cells. Th3 cells have been identified as TGF-β-producing CD4 + LAP + T cells exhibiting TGF-β-mediated suppression [26] . Tr1 cells have been characterized by the higher production of IL-10 and IL-10-mediated suppressive functions [27] .
T helper 3 cellsl
Th3 cells were first found in mesenteric lymph node CD4 + T cells as single cell clones producing TGF-β1 after oral administration of self-antigen [28] . Oida 
Foxp3
-T cells in colorectal tumors expressed LAG3 and exhibited inhibitory functions through TGF-β1 and IL-10 [32] . To date, the specific transcription factor for Th3 cells remains to be identified.
Type 1 regulatory T cells
The first study on Tr1 cells reported that naïve T cells repeated stimulation with peptide-pulsed splenocytes in the presence of IL-10 induced IL-10-producing CD4 + T cells with suppressive ability and hypoproliferative ability [33] . Akbari et al. demonstrated that bronchial DCs promoted Tr1 cells in vitro in an IL-10-and ICOS/ ICOS ligand (ICOSL)-dependent manner in the context of nasal tolerance [34] . By microarray analysis Tr1 and Th0 cell clones, CD49b, LAG3, and CD226 have been identified as the surface markers of Tr1 cells [35] .
It has been shown that c-Maf transactivated IL-10 expression under CD4 + Th17 polarization conditions [36] . Aryl hydrocarbon receptor (AhR) and c-Maf facilitated IL-10 production in CD4 + T cells in an IL-27-dependent fashion [37, 38] . Another study reported that c-Maf, IL-21, and ICOS were essential for IL-27-induced Tr1 cell generation [39] . Consistent with these observations, Awasthi et al. showed that CD4 + Foxp3 + regulatory T cell-educated DCs produced IL-27 and promoted Tr1 cell generation [38] . Nasal anti-CD3ɛ antibody treatment induced the expression of IL-10, IL-27, and TGF-β in nasal tolerogenic DCs, which further facilitated Tr1 cell generation through c-Maf, IL-21, and AhR [40] . Orally antigen treated tolerogenic Peyer's patch DCs increased the production of IL-10 and IL-27 and promoted the induction of Tr1 cells [41] . Carrier et al. reported that constitutive ectopic expression of GITR ligand (GITRL) on MHCII + APCs increased IL-27 production and further upregulated the expression of c-Maf and IL-10 in T cells [42] .
In addition to cytokines, reports have demonstrated that Tr1 cells could be induced by different proteins, different APCs, and different types of T cells. Galectin-1 promoted IL-10 expression in CD4 + T cells in an APCindependent pathway by binding to CD45 on T cells and inducing the expression of c-Maf and AhR [43] . In vitro activation of CD4 + CD44 hi Foxp3 -T cells through anti-CD3/CD28 antibodies and IL-2 generated CD49b-, LAG3-, c-Maf-, and AhR-expressing Tr1 cells [44] . Nie et al. found that long-term stimulation of lipopolysaccharide (LPS) conferred ICOSL expression in bone marrow-derived mast cells through NF-κB, subsequently promoting Tr1 cell development [45] . These reports suggest that the generation mechanisms for Tr1 cells consist of a fine-tuning program.
B cells in tolerance induction
B cells have been shown to have a role in the fine equilibrium for immune tolerance. Genetically B-celldeficient mice delayed recovery from experimental autoimmune encephalomyelitis and suggested B cells might contribute to immune modulation [46] . Collagen fragments expressed on B cell MHC class II sufficiently delayed the onset and decreased the severity of arthritis [47] . The role of B cells in oral tolerance has been investigated because B-cell-deficient mice exhibit a defective oral tolerogenic response characterized by lower levels of IL-10 and TGF-β in the spleen and gut-associated lymphoid tissues [48] . Gutgemann et al. showed that B cells interacted with T cells at the B-T border in the spleen after 4 h of oral administration of proteins [49] . Furthermore, orally antigen treated B cells have an enhanced ability to induce CD4 + regulatory T cells in vitro [50] . Anterior chamber-associated immune deviation was characterized by antigen-specific downregulation of the immune response to antigen occurs in the anterior chamber of the eye [51] , and this phenomenon was abrogated in the absence of B cells [52] . Studies suggested that splenic B cells presented antigens derived from ocular APCs and induced CD4 + CD25
+ regulatory T cells via IL-10 and MHC class II [52, 53] . These evidence emphasize the role of B cells in the induction and maintenance of self-tolerance.
There is accumulating evidence demonstrating that specific B cell subsets modulate immune responses named as regulatory B (Breg) cells by Mizoguchi et al. [54] . Breg cells dampened immune responses though the secretion of IL-10, TGF-β, directly interact with activated CD4 + T cells, and the production of antibody that neutralized harmful soluble molecules [55] . Several Breg cells have been described in mice and IL-10-producing Breg cells are the most widely studied [56] . IL-10 produced by a variety of Breg cells suppressed inflammatory cytokines and promoted regulatory T cell differentiation [57, 58] . These indicate that B cells contribute to the maintenance of tolerance.
In addition, naïve B cells functioned as antigenpresenting cells presented antigen and resulted in T cell tolerance to antigen [59] . Raimondi et al. demonstrated that adoptive transfer of antigen-presenting B cells four times in a week lead to antigen-specific CD4 + T cells tolerance independent of naïve or activated B cells [60, 61] . Antigen-presenting follicular B, marginal zone B, and B-1a cells rendered antigen-specific T cells hyporesponsiveness without Foxp3
+ Treg cells induction [62] . One study reported that B cells contributed to Treg cells homeostasis and cooperated with Treg cells to ameliorate inflammation [63] . These findings suggest that B cells play a role in immune modulation and might through the manipulation of CD4 + Treg cells. regulatory T cell generation [65] . In our reports, transwell insertion during B-T coculture abrogated Treg-of-B cell induction suggesting that cell-cell contact between B and T cells was essential. By applying blocking antibodies during B-T coculture, both CD80 and CD86 on splenic B cells were required to induce functional Treg-of-B [64] . In consistent with above, Etemire et al. demonstrated that addition of anti-CD28 antibody to the B-T cell co-culture decreased the suppressive activity of Treg-of-B cells. Lower activity of the PI3K/AKT pathway was associated with Foxp3 -regulatory T cell generation [66] . IL-10-deficient Treg-of-B cells and Treg-of-B cells induced in the presence of anti-IL-10 neutralizing antibody remained their suppressive function suggesting that IL-10 was not critical for their induction [64, 67, 68] . These results suggest that the interaction between B-T cells is indispensable for the differentiation of Treg-of-B cells.
Treg-of-B cells differ from well-known Treg cells
To date, several molecules have been identified for their strong association with Treg-of-B cells that are conserved in single peptide-induced and anti-CD3/CD28 antibodies-induced methods. Treg-of-B cells expressed higher levels of LAG3, ICOS, PD1, GITR, OX40 (CD134), and CTLA4 compared to those on naïve CD4 + CD25 -T cells (Fig. 1 
Foxp3
-IL-10-producing regulatory T cells [65] . Our published and unpublished data showed that Treg-of-B cells did not express Foxp3, Helios, or neuropilin-1 [67, 69] , and these also confirmed by using Foxp3-GFP reporter mice [64] . These evidence differentiates Treg-of-B cells from Foxp3-expressing Treg cells (Table 1) .
Th3 cells are well-known that they exert TGF-β-dependent inhibition and express LAP on surface [26] . Although Treg-of-B cells produced TGF-β compared with naïve CD4 + CD25 -T cells [68, 69] , TGF-β did not play a role in their suppressive mechanism [64] . In our unpublished data, Treg-of-B cells did not express LAP. These indicate that Treg-of-B cells are different from Th3 cells.
Tr1 cells are characterized by IL-10-mediated suppression and the higher production of IL-10 [27] . In recent years, CD49b, LAG3, and CD226 were identified as the surface markers for human and mouse Tr1 cells [35] . In our results, Treg-of-B cells produced a higher amount of IL-10 compared with naïve CD4 + CD25 -T cells [50, 64] . Repeated stimulation of B cells induced long-term Tregof-B cells with higher expression of ICOS, CTLA4, CD49b, and c-Maf, but not CD226. In addition to the difference in surface marker, IL-10 seems to be dispensable in the inhibitory mechanism of Treg-of-B cells and these would be described in the later section. These observations suggest that this Treg-of-B cell is a new type of regulatory T cells and different from Tr1 cells.
In addition to regulatory T cells, Treg-of-B cells did not share characteristics with follicular T helper (T FH ) cells. T FH cells expressed BCL-6, CXCR5, ICOS, PD1, and c-Maf and CXCR5 conferred T FH cells migration to B follicles [67, 70] . Although Treg-of-B cells expressed ICOS, PD1 and c-Maf, they did not express the critical molecule BCL-6 and CXCR5 (data not shown). These indicate that Treg-of-B cells could not migrate into follicle to facilitate B cell as T FH cells did.
Furthermore, Treg-of-B cells were hypoproliferative to stimulation and did not express T-bet, GATA3, or RORγt ( [64] and our unpublished data). Treg-of-B cells produced higher level of IL-10, TGF-β, and IL-4 and lower or no IL-2, IFN-γ, IL-17, or tumor necrosis factor (TNF)-α [68, 69, 71] . These data confirm that Treg-of-B cells have anergic characteristics and are not proinflammatory T helper cells.
Application of Treg-of-B cells
The therapeutic effects of CD4 +
Foxp3
-Treg-of-B cells has been described in several murine disease models (Fig. 2) . Adoptive transfer of Treg-of-B cells prevented mice from graft-versus-host disease in a murine model of heart transplantation [65] . Peyer's patch B-cellinduced ovalbumin (OVA)-specific Treg-of-B cells protected mice from Th2-cell-mediated airway hyperresponsiveness (AHR), airway inflammation, and IgE hyperproduction in allergic asthma in an antigen-specific fashion [50] . In addition, splenic B-cell-induced OVA-specific Tregof-B cells shared several characteristics with oral antigen administration activated CD4 + CD25 + T cells, including elevated expression levels of ICOS, PD1, and CTLA4 and enhanced non-antigen-specific suppressive functions [69] . Monoclonal antibody-induced Treg-of-B cells prevented mice from osteolysis and joint inflammation in collageninduced arthritis [71] . Prophylactic transfer of Treg-of-B cells also protected mice from T-cell-induced Th1-and Th17-dominant inflammatory bowel disease [68] . Taken together, naïve B cell without cytokines or chemical supplements is able to induce functional CD4 +
-regulatory T cells and that B-cell-induced regulatory T cells is an economical strategy for cellular therapy for different T-helpercell-dominant inflammatory diseases.
Treg-of-B cells possess both IL-10-dependent and IL-10-independent suppressive functions IL-10 as an anti-inflammatory cytokine is an issue in Treg-of-B cells suppressive function. As described above, IL-10 does not play a crucial role in Treg-of-B cells differentiation. Chen and Chu et al. reported that LAG3 + Treg-of-B cells produced higher amount of IL-10 and both IL-10 and LAG3 play the roles in their inhibitory mechanisms [71, 72] . Long-term Treg-of-B cells increased expression levels of CTLA4 and IL-10, both of which were involved in their suppressive functions [67] . IL-10-deficient mice were used to confirm the role of IL-10 in the regulation; however, IL-10-deficient Tregof-B cells remained suppressive activities [64, 68] . IL-10 seems to be dispensable in the inhibitory mechanism of Treg-of-B cells. Although IL-10 plays a more important role in long-term Treg-of-B cells than in short-term Treg-of-B cells, three-day short-term culture is sufficient Studies have demonstrated that ICOS controls IL-10 production and functional CTLA4 expression in Treg cells [73] [74] [75] . PD1 recruits SHP-1 and SHP-2 to intrinsically downregulate T cell receptor signaling, which maintains an anergic phenotype in Treg cells [76, 77] . Mouse Treg cells constitutively expressed GITR and OX40 and involved the tTreg cells development as well as their functions [78] [79] [80] . All regulatory-T-related molecules on Treg-of-B cells, including IL-10, TGF-β, LAG3, CTLA4, ICOS, PD1, GITR, and OX40, might confer partial suppressive activities to compensate for single blockage or neutralization. The critical molecules controlling Treg-of-B cell phenotype and regulatory mechanisms remain priorities for investigation. The inhibitory functions of Treg-of-B cell depend on the suppressive molecules on the surface or soluble mediators that require short distance. + regulatory T cells more efficiently than immature DCs [84, 85] . In contrast, reports demonstrated that murine CD40-activated B cells promoted CD4 + T cell proliferation and effector functions [86, 87] . Furthermore, the frequency of intrathymic B cells correlated with that of tTreg cells, and B cells colocalized with tTreg cells in the thymus [88, 89] . Intrathymic B cells expressed autoimmune regulator (Aire), increased the levels of MHC class II and CD80, and contributed to T cell negative selection for central T cell tolerance [90, 91] . Taken together, there are unknown criteria, such as MHC class II-TCR signaling, the B cell activation status, and different types of tissue resident B cells, that may fine-tune the expression of Foxp3 in B-cellinduced regulatory T cells.
Conclusions
To date, we know that naïve antigen-presenting B cell is sufficient to induce CD4 + Foxp3 -regulatory T cells without additional cytokines or chemicals in an IL-10-and IL-27-dispensable and cell-cell contact-dependent manner. The expression levels of characteristic molecules differentiate Treg-of-B cells from well-known T helper and regulatory T cells as a brand-new type of CD4 + Foxp3 -regulatory T cells (Fig. 1) . Treg-of-B cells possess IL-10-depedent, IL-10-independent, and cell-cell contact-dependent suppressive abilities in antigenspecific and non-antigen specific fashions. Compared to long-term Treg-of-B cells, short-term Treg-of-B cells act through multiple suppressive pathways, and thus a blockade strategy would be more easily overcome through compensation by other pathways. Treg-of-B cells exhibit immunomodulatory effects in Th2-, Th1-, and Th17-medated diseases and even allogeneic transplantation. Nevertheless, the physiological conditions or cues necessary for Treg-of-B cell generation remain unknown. What is the fine-tuning mechanism for B cells to induce CD4 
